2022-501423-25-00CompletedPhase 1/2
A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytoma
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Sept 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 54 (actual)
- First submitted
- 21 Nov 2022
- Start date
- 5 May 2023
- Lead sponsor
- Curevac AG
- Diseases
- Glioblastoma
- EU CT number
- 2022-501423-25-00
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 54
- 13 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (13)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UZ Brussel | Jette | Belgium | Completed |
| CHU de Liège | Liège | Belgium | Completed |
| Universitaetsklinikum Bonn AöR | Bonn | Germany | Completed |
| Universitaetsklinikum Essen (AoR) | Essen | Germany | Completed |
| Goethe University Frankfurt | Frankfurt Am Main | Germany | Completed |
| Medical Center- University of Freiburg | Freiburg im Breisgau | Germany | Completed |
| Heidelberg University Hospital AöR | Heidelberg | Germany | Completed |
| Universitätsklinikum Leipzig AöR | Leipzig | Germany | Completed |
| Universitat Heidelberg | Mannheim | Germany | Completed |
| Klinikum der Universitaet Muenchen AöR | Munich | Germany | Completed |
| Universitaetsklinikum Regensburg | Regensburg | Germany | Completed |
| Universitaetsklinikum Tuebingen | Tuebingen | Germany | Completed |
| Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Rotterdam | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.